With deep experience supporting all major markets and therapeutic areas within MedTech, the MedTech Center of Excellence delivers Trinity’s best-in-class life sciences commercialization services and products to our partners in the device, diagnostics, medical supplies and digital health industries.
Trinity MedTech meets our partners where they are at in their commercialization journey to provide cutting-edge guidance grounded in insights, data and analytics.
As a foundational area of expertise for the MedTech COE, we help our medical device partners navigate product innovation, the shift to non-acute, robotics and complex competitive landscapes in a post-COVID world. We push manufacturers to move from a features-and-benefit play to one of outlining economic value. We use Trinity’s deep network of KOLs/clinicians, hospital administrators and payers to shape the growth trajectory of key players in cardiovascular, surgical specialties, neuroscience and orthopedics.
While many of the types of engagements we help our clients with are the same, the questions are unique when it comes to digital strategy. Trinity MedTech supports clients across strategic and commercial decision making for digital health investments, from clinical decision support systems (CDSS) to digital therapeutics (DTx). We differentiate by leveraging Trinity’s data science and software development capabilities.
We help diagnostics companies devise innovative strategies to capture value for advanced diagnostics, from companion diagnostics (CDx) to liquid biopsy (LBx) to -Omics. We also offer deep expertise to support Trinity’s pharmaceuticals clients as they incorporate precision medicine into their product strategies.
Trinity leverages dedicated MedTech experts on our Evidence Strategy and Value, Access and Pricing teams to help our partners keep up with the fast-evolving hurdles and opportunities of value-based healthcare and create winning value stories.
Business development/mergers & acquisitions
Forecasting
Product innovation/early commercialization
Global marketing strategy
Opportunity assessments
Commercial/sales execution and analytics
Blog
The Next Wave of Global AI Medical Devices: Innovation in Action
A recent bipartisan initiative by Senators Martin Heinrich, Mike Rounds, Marsha Blackburn and Todd Young urged the Centers for Medicare & Medicaid Services (CMS) to establish a formal payment pathway for algorithm-based health care services (ABHS). This move addresses the need for stable Medicare reimbursement for FDA-cleared AI and machine learning (ML) medical devices, which […]
Read More
Webinars
Payer Predictions: Evolution of the U.S. Digital Therapeutics Reimbursement Landscape
Available On Demand
The digital therapeutics (DTx) market is growing rapidly, but a lack of clarity around their reimbursement framework in the U.S. means that there is limited coverage. DTx developers— and pharmaceutical organizations seeking an integrated digital offering— are left to wonder how the payer landscape will evolve as they strategize for the future. Join Trinity Life […]
Watch Now
Webinars
Ambulatory Surgical Centers: How to Secure Commercial Targeting Success in 2023
Available On Demand
Experts from Trinity Life Sciences’ MedTech team partner with guest speaker, Mayuri Shah from Bain & Co., to deliver insights drawn from real case studies to inform how your organization can strengthen its commercial targeting and engagement strategies for ambulatory surgical centers (ASCs). Register for this webinar to understand: Click here to read our advisory brief […]
Watch Now
Partner &
Head of MedTech
Partner,
Evidence Strategy
Partner & Head of
Real World Evidence
If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.
